Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.
Press releases published on June 10, 2025

Lantheus to Present at the 2025 Truist Securities MedTech Conference
BEDFORD, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, …

GSAC Engineering Secures Multi-Year Recurring Revenue Contract
MIAMI, June 10, 2025 (GLOBE NEWSWIRE) -- GelStat Corporation ("GelStat" or the "Company") (OTC: GSAC), a development stage company currently focused on the research, development, and marketing of engineered solutions for the industrial security industries, …

Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025
CAMBRIDGE, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will participate in a fireside chat at the Truist …

Opus One Gold Obtains 4.10 G/T Gold Over 7.1 M From Hole No-25-13, At 550 Vertical Meters On Its Zone 1 Gold Discovery, Noyell Project
NOT FOR DISTRIBUTION TO U.S NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTREAL, June 10, 2025 (GLOBE NEWSWIRE) -- Opus One Gold Corp (TSX-V: OOR) (the “Company” or “Opus One”) is pleased to announce that drill hole NO-25-13 from the …

Opus One Gold Obtient 4,10 G/T d'or Sur 7,1 M À Partir Du Trou No-25-13, À 550 Mètres Verticaux Sur Sa Découverte d'or De La Zone 1, De Son Projet Noyell
NE PAS DISTRIBUER AUX SERVICES DE FIL DE PRESSE AMÉRICAINS NI DIFFUSER AUX ÉTATS-UNIS MONTREAL, 10 juin 2025 (GLOBE NEWSWIRE) -- Corporation Aurifère Opus One (TSX-V : OOR) (la « Société » ou « Opus One ») est heureuse d'annoncer Le sondage NO-25-13, issu …

Enlivex Therapeutics to Present Clinical Data of Allocetra in Osteoarthritis at EULAR 25 European Congress of Rheumatology
Ness-Ziona, Israel, June 10, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that it will present a poster at the European Alliance of …

Brag House Explores NIL Initiative to Expand Revenue Opportunities for Student-Athletes
NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Brag House Holdings, Inc. (NASDAQ: TBH) (“Brag House” or the “Company”), the media-tech platform at the intersection of gaming, college sports, and Gen Z engagement, today announced that it plans to develop a …

Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium
SARASOTA, Fla., June 10, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company developing intranasal therapeutics for brain-related conditions, today announced that Greg Gironda, Head of Business Development, will present …

Vivani Medical to Present at the 2025 BIO International Convention
ALAMEDA, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (the “Company” or “Vivani”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, announced today that CEO Adam Mendelsohn, …

Day One Appoints Michael Vasconcelles, M.D., as Head of Research and Development
Dr. Michael Vasconcelles brings more than 25 years of extensive oncology research, development and health technology expertise and corporate executive leadership to Day One Dr. Vasconcelles to drive pipeline creation and execution BRISBANE, Calif., June 10 …

Historic Executive Order Fast-Tracks ZenaTech’s ZenaDrone Subsidiary Manufacturing and Go-to-Market Plans for Dual-Use Defense and Commercial Drones
VANCOUVER, British Columbia, June 10, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS, and …

Genius Group Acquires Entrepreneur Resorts, Expands Genius City Model with 50% Increase in 2025 Revenue Guidance
SINGAPORE, June 10, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced that it has signed a binding asset purchase agreement with …

Primech AI, Subsidiary of Primech Holdings Wins Robotics Category at Singapore Business Review Technology Excellence Awards 2025
SINGAPORE, June 10, 2025 (GLOBE NEWSWIRE) -- Primech AI Pte. Ltd. (“Primech AI” or the “Company”), a subsidiary of Primech Holdings Limited (Nasdaq: PMEC), today announced that it has been named Winner in the Robotics category at the prestigious Singapore …

2Checkout Will Host the 9th Edition of CommerceNow Event, Inspiring Businesses to Amplify the Way They Sell Online
NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- 2Checkout, a global leader in payment and commerce solutions for cross-border digital sales, today announces that its highly anticipated 9th edition of CommerceNow, will take place on June 18-19, 2025. The …

Outlook Therapeutics® Announces SMC Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
ISELIN, N.J., June 10, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced the Scottish Medicines …

Solar PV Module Market worth $97.56 billion by 2032, booming at 8.4% CAGR, Coherent Market Insights
Burlingame, CA, June 10, 2025 (GLOBE NEWSWIRE) -- Coherent Market Insights published a report, titled, the global Solar PV Module Market size is calculated at USD 55.45 billion in 2025 and is forecasted to reach around USD 97.56 billion by 2032, …

Ashvattha Therapeutics to Present Phase 2 DME and Wet AMD Data at Clinical Trials at the Summit and MaculArt
Ashvattha will present Phase 2 data on migaldendranib, a subcutaneous therapy for DME and wet AMD, which could offer a more patient-friendly alternative to current injection-based treatments Company is exploring new technology to normalize VEGF expression, …

Worthington Enterprises Schedules Fourth Quarter 2025 Earnings Call for June 25
COLUMBUS, Ohio, June 10, 2025 (GLOBE NEWSWIRE) -- Worthington Enterprises Inc. (NYSE: WOR) will hold its quarterly earnings conference call Wednesday, June 25 at 8:30 a.m. ET. The Company will discuss its fiscal fourth quarter results, which will be …

MBX Biosciences to Present at the American Diabetes Association 85th Scientific Sessions
CARMEL, Ind., June 10, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic …

Only 11% of Teams Have Scaled AI: Order.co’s 2025 Benchmark Report Reveals Urgent Gap in Procurement, Finance, and Ops
NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Order.co, the world’s leading B2B Ecommerce Platform, today announced its release of an exclusive report, The State of AI in Procurement, Finance …